Townsend Richard Nolan 4
4 · Lexeo Therapeutics, Inc. · Filed Feb 21, 2025
Insider Transaction Report
Form 4
Townsend Richard Nolan
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-02-19$4.41/sh−4,326$19,091→ 220,119 total
Footnotes (2)
- [F1]Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").
- [F2]Includes 136,562 RSUs.